-
focus on honing expertise and research acumen in the areas of adolescent firearm injuries and death, mental health, traumatic stress, and defining trauma networks to identify children and young adults
-
system to determine cellular networks that lead to cell death and to establish molecules that can prevent degeneration. Experimental approaches being used in the lab include inner ear drug delivery, CRISPR
-
Chronic Conditions (ADACC) Network. This consortium will consist of multidisciplinary investigators dedicated to developing evidence-based strategies for the use and implementation of biomarkers
-
neuroimaging and fluid biomarkers, (b) systems biology analysis of pathways from multi-omics data using multi-layered network approaches, © machine learning for identification of genetic risk factors in ADRD, (d
-
fellows with special interest in human connectomics in Alzheimer’s disease (AD). The Lab’s overarching goals are 1) to achieve a better understanding of the brain network and neurophysiological mechanisms
-
Levin (USGS, Upper Midwest Water Science Center). This position offers opportunities for professional development through the USGS network and collaboration with hydrologists, climatologists, and data
-
, Bloomington seeks a talented, highly motivated researcher with a background in medical sociology, social networks, sociology of aging, social neuroscience, social genetics/epigenetics, and/or quantitative
-
fellows with special interest in human connectomics in Alzheimer’s disease (AD). The Lab’s overarching goals are 1) to achieve a better understanding of the brain network and neurophysiological mechanisms
-
neuroimaging and fluid biomarkers, (b) systems biology analysis of pathways from multi-omics data using multi-layered network approaches, © machine learning for identification of genetic risk factors in ADRD, (d
-
system to determine cellular networks that lead to cell death and to establish molecules that can prevent degeneration. Experimental approaches being used in the lab include inner ear drug delivery, CRISPR